North American Neuromodulation Society
Contains 0 items
Subtotal: $0.00



Pre-Clinical Studies of Genetic Role in Pain Control – Recorded Webinar

  

Pricing and Registration

  • NANS Member: Free
  • Non-Member: Free 

Description

This webinar will focus on the gene sequencing of the dorsal spinal cord, including RNA and biomarkers. It will also provide a background on the interactions of neurons and glial cells. Faculty will present the following topics:

  • Gene Sequencing
  • Modeling a Glial-Neuronal Interaction
  • Genetic/Proteomic Evaluation of Chronic Pain and SCS Treatment

Target Audience

This webinar is designed for physicians, advanced practice providers, and fellows.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the anatomy and concentration of glial cells in neurons in the dorsal spinal cord.
  • Describe the function of each cell type.
  • Discuss the pathophysiology of the chronic pain cascade within the spinal cord.

Faculty

  • David L. Cedeno, PhD
  • Dana M. Tilley, PhD
  • Yun Guan, MD PhD

Planners

  • Steven M. Falowski, MD
  • Ahmed M. Raslan, MD 

Commercial Support

This educational activity is supported by an educational grant from Medtronic. 

Disclaimer

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the NANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.

Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the Congress of Neurological Surgeons, as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest to the program participants prior to the start of the activity. 

CNS is also required to manage any reported conflict and eliminate the potential for bias during the activity. All conflicts of interest have been resolved in accordance with ACCME’s Standards for Commercial Support.  

It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. 

Please find the relevant financial relationships disclosed below for all individuals in control of content. Activity Planners are designated with a (P). Planners, faculty, and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.

 Name Relationship/Company 

David L. Cedeno, PhD

Consulting Fee – Medtronic

Steven M. Falowski, MD (P)

Consulting Fee – Abbott, Boston Scientific, Medtronic, Vertiflex, Vertos
Contracted Research – Abbott, Boston Scientific, Medtronic, Stimgenics, Vertiflex
Ownership Interest (Future Stock Options) – Celeri, CornerLoc, PainTeq, Saluda Medical, SPR Therapeutics, Stimgenics, Thermaquil

Yun Guan, MD PhD  Contracted Research – Medtronic, Tissue Tech
Dana M. Tilley, PhD  Consulting Fee – Stimgenics

Accreditation & Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Congress of Neurological Surgeons (CNS) and the North American Neuromodulation Society. The CNS is accredited by ACCME to provide continuing medical education for physicians.

The CNS designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Criteria for Successful Completion 

  • Take a pre-test
  • Watch the entire previously recorded presentation (live event was held 11/12/2020)
  • Achieve a passing score of 70% or higher on the post-test
  • Completion/submission of evaluation form

Claiming CME Credit

CME credit will only be awarded after successful completion of the activity. After passing the post-test and completing the evaluation, you will be able to print and save a copy of your CME certificate.
 
This activity was published on November 26, 2020. Credit may be obtained until May 31, 2021.
 
After purchasing the webinar, you will receive a confirmation email containing the specific webinar link. If you do not receive a confirmation, please contact NANS Member Services at 847.375.4714 or info@neuromodulation.org.
 

Purchase Webinar

WIKISTIM

WIKISTIM is a searchable database being populated with data published in the field of neuromodulation. The goals of WIKISTIM are to improve patient care and the quality of research reports, foster communication, reveal research needs, and support the practice of evidence–based medicine.

NANS Events  

  • JUNE 25-26, 2021

    NANS-NIC Joint Meeting
    Virtual

  • JULY 15-17, 2021

    NANS Mid-Year Meeting
    Walt Disney World Swan & Dolphin Resort
    Orlando, FL

  • Sept. 16-17, 2021

    NANS Cadaver Course
    Oquendo Center
    Las Vegas, NV

  • Jan. 13-15, 2022

    NANS 25th Annual Meeting
    Walt Disney World Swan & Dolphin Resort
    Orlando, FL

Contains 0 items
Subtotal: $0.00